Loading…
Back To Schedule
Monday, September 19 • 8:45am - 9:30am
Keynote Panel: Evolution of Portfolio Optimization and Management

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
As companies look to consolidate pipelines, what are the pros and cons of doing one over another and how to evaluate which projects to prioritize and which projects to remove from the portfolio.
  • Showcase how the role of portfolio management has transformed due to rising costs, intentionally consolidating pipelines, and reimbursement hurdles and is more focused on a balanced approach
  • Discover how companies assess the value and risk of each asset and choose new projects for both short-term cash flow and long-term development
  • Explain how to determine the risk associated with the reimbursement landscape and what level of risk evaluation is critical for prioritization decisions
Moderators
avatar for Raquel Cabo

Raquel Cabo

Vice President, Global Commercial Strategy, Ovid Therapeutics
Raquel is the VP of Global Commercial Strategy Ovid Therapeutics, where she leads commercial strategy and planning for the company’s epilepsy and gene therapy programs. Raquel joined the company in 2015. During her tenure at Ovid, she has had leadership roles in Market Access, HEOR... Read More →

Speakers
avatar for Matt Schindel, MBA

Matt Schindel, MBA

Director, Portfolio Management and Operations, AstraZeneca Rare Disease
Matt is currently Director of Portfolio Management at AstraZeneca Rare Disease, formerly Alexion Pharmaceuticals, responsible for the R&D portfolio management processes, including prioritization and PTRS assessments. In addition to portfolio management, Matt leads resource forecasting... Read More →
avatar for Kara Malewicz

Kara Malewicz

Vice President of New Product Commercialization Strategy, Ionis Pharmaceuticals, Inc.
avatar for Aziz Mottiwala

Aziz Mottiwala

Chief Commercial Officer, Tarsus Pharmaceuticals, Inc.
Aziz has over 20 years of biopharmaceutical industry leadership experience in several therapeutic areas, including over 10 years in the eye care space. Prior to joining Tarsus, Aziz was Chief Commercial Officer at Opiant Pharmaceuticals, overseeing all aspects of commercial strategy... Read More →

Monday September 19, 2022 8:45am - 9:30am EDT
  General Session